BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29635711)

  • 21. ABCB4 sequence variations in young adults with cholesterol gallstone disease.
    Nakken KE; Labori KJ; Rødningen OK; Nakken S; Berge KE; Eiklid K; Raeder MG
    Liver Int; 2009 May; 29(5):743-7. PubMed ID: 19018976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ABCG5/8 cholesterol transporter and myocardial infarction versus gallstone disease.
    Stender S; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
    J Am Coll Cardiol; 2014 May; 63(20):2121-2128. PubMed ID: 24657701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mice overexpressing hepatic Abcb11 rapidly develop cholesterol gallstones.
    Henkel A; Wei Z; Cohen DE; Green RM
    Mamm Genome; 2005 Dec; 16(12):903-8. PubMed ID: 16341669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrence of gallstones after cholecystectomy is associated with ABCG5/8 genotype.
    von Schönfels W; Buch S; Wölk M; Aselmann H; Egberts JH; Schreiber S; Krawczak M; Becker T; Hampe J; Schafmayer C
    J Gastroenterol; 2013 Mar; 48(3):391-6. PubMed ID: 22869156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lith genes control mucin accumulation, cholesterol crystallization, and gallstone formation in A/J and AKR/J inbred mice.
    Lammert F; Wang DQ; Wittenburg H; Bouchard G; Hillebrandt S; Taenzler B; Carey MC; Paigen B
    Hepatology; 2002 Nov; 36(5):1145-54. PubMed ID: 12395324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Mitochondrial DNA Variant Elevates the Risk of Gallstone Disease by Altering Mitochondrial Function.
    Sun D; Niu Z; Zheng HX; Wu F; Jiang L; Han TQ; Wei Y; Wang J; Jin L
    Cell Mol Gastroenterol Hepatol; 2021; 11(4):1211-1226.e15. PubMed ID: 33279689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic evidence that apolipoprotein E4 is not a relevant susceptibility factor for cholelithiasis in two high-risk populations.
    Mella JG; Schirin-Sokhan R; Rigotti A; Pimentel F; Villarroel L; Wasmuth HE; Sauerbruch T; Nervi F; Lammert F; Miquel JF
    J Lipid Res; 2007 Jun; 48(6):1378-85. PubMed ID: 17384433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissecting the genetic heterogeneity of gallbladder stone formation.
    Krawczyk M; Wang DQ; Portincasa P; Lammert F
    Semin Liver Dis; 2011 May; 31(2):157-72. PubMed ID: 21538282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes.
    Wang DQ; Afdhal NH
    Curr Gastroenterol Rep; 2004 Apr; 6(2):140-50. PubMed ID: 15191694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity.
    Shaffer EA; Small DM
    J Clin Invest; 1977 May; 59(5):828-40. PubMed ID: 856870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphism of sterol transporters in children with future gallstones.
    Nissinen MJ; Pitkänen N; Simonen P; Gylling H; Viikari J; Raitakari O; Lehtimäki T; Juonala M; Pakarinen MP
    Dig Liver Dis; 2018 Sep; 50(9):954-960. PubMed ID: 29764733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The genetic background of gallstone formation: an update.
    Marschall HU; Katsika D; Rudling M; Einarsson C
    Biochem Biophys Res Commun; 2010 May; 396(1):58-62. PubMed ID: 20494111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gallstone disease: from genes to evidence-based therapy.
    Lammert F; Miquel JF
    J Hepatol; 2008; 48 Suppl 1():S124-35. PubMed ID: 18308417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An update on the pathogenesis and treatment of cholesterol gallstones.
    Portincasa P; van de Meeberg P; van Erpecum KJ; Palasciano G; VanBerge-Henegouwen GP
    Scand J Gastroenterol Suppl; 1997; 223():60-9. PubMed ID: 9200309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mouse models of gallstone disease.
    Wang TY; Portincasa P; Liu M; Tso P; Wang DQ
    Curr Opin Gastroenterol; 2018 Mar; 34(2):59-70. PubMed ID: 29266008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic predisposition to gallbladder stones.
    Wittenburg H; Lammert F
    Semin Liver Dis; 2007 Feb; 27(1):109-21. PubMed ID: 17295180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and functional identification of the likely causative variant for cholesterol gallstone disease at the ABCG5/8 lithogenic locus.
    von Kampen O; Buch S; Nothnagel M; Azocar L; Molina H; Brosch M; Erhart W; von Schönfels W; Egberts J; Seeger M; Arlt A; Balschun T; Franke A; Lerch MM; Mayerle J; Kratzer W; Boehm BO; Huse K; Schniewind B; Tiemann K; Jiang ZY; Han TQ; Mittal B; Srivastava A; Fenger M; Jørgensen T; Schirin-Sokhan R; Tönjes A; Wittenburg H; Stumvoll M; Kalthoff H; Lammert F; Tepel J; Puschel K; Becker T; Schreiber S; Platzer M; Völzke H; Krawczak M; Miquel JF; Schafmayer C; Hampe J
    Hepatology; 2013 Jun; 57(6):2407-17. PubMed ID: 22898925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of disease: the genetic epidemiology of gallbladder stones.
    Lammert F; Sauerbruch T
    Nat Clin Pract Gastroenterol Hepatol; 2005 Sep; 2(9):423-33. PubMed ID: 16265433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular genetics of cholesterol cholelithiasis: identification of human and murine gallstone genes].
    Figge A; Matern S; Lammert F
    Z Gastroenterol; 2002 Jun; 40(6):425-32. PubMed ID: 12055667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of gallstones.
    Carey MC
    Recenti Prog Med; 1992; 83(7-8):379-91. PubMed ID: 1529152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.